Also listed on Aeris Therapeutics, LLC, an earlier holder on the record. The recorded assignments below show how it moved.
Collateral for a security interest recorded Mar 2, 2026 (Perceptive Credit Holdings V, LP).
Term ends Jul 23, 2029 · High confidence
20-year base term ends Sep 26, 2027
Held by Pulmonx Corporation
Filed May 19, 2009 as application 12/443,021 · Granted Jan 29, 2013
Base term plus 666 days of patent term adjustment (USPTO delay)
Today
2007
2029
Clock starts
Sep 26, 2007
Sep 26, 2007
Term ends
Jul 23, 2029
Jul 23, 2029
Granted
Jan 29, 2013
Jan 29, 2013
base term
patent term adjustment
fee events
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
666
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 666 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 26, 2007, when application PCT/US2007/079504, the earliest non-provisional in its chain, was filed (this one was filed May 19, 2009) | Sep 26, 2027 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +666 days, USPTO patent term adjustment record | Jul 23, 2029 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jul 23, 2029 | High confidence |
This family
| Application PCT/US2007/079504 | PCT application no patent term | no patent term |
| US 8,361,484 | this patent Jul 2029 | Jul 2029 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 20, 2009 Reel 22707, frame 144 | Ingenito, Edward P.; Schwarz, Alexander; Tsai, Larry W. | Aeris Therapeutics, Inc. | Assignment of Assignor's Interest |
| Nov 10, 2009 Reel 23486, frame 719 | Aeris Therapeutics, LLC | Rosse Enterprises, Ltd. | Security Agreement |
| Apr 22, 2011 Reel 26170, frame 254 | Aeris Therapeutics, Inc. | Aeris Therapeutics, LLC | Assignment of Assignor's Interest |
| Feb 9, 2012 Reel 27683, frame 3 | Aeris Therapeutics, LLC | Rosse Enterprises, Ltd. | Security Agreement |
| May 26, 2015 Reel 35714, frame 886 | Rosse Enterprises, Ltd. | Aeris Therapeutics, LLC. | Release of Security Interest |
| May 15, 2017 Reel 42466, frame 349 | Pulmonx Corporation | Oxford Finance LLC, as Collateral Agent | Security Interest |
| Jul 26, 2017 Reel 43349, frame 725 | Pulmonx Corporation | Boston Scientific Corporation | Security Interest |
| Mar 25, 2019 Reel 48682, frame 506 | Aeris Therapeutics, LLC. | Pulmonx | Assignment of Assignor's Interest |
| Apr 23, 2019 Reel 48964, frame 822 | Pulmonx | Pulmonx Corporation | Merger |
| Mar 2, 2020 Reel 52916, frame 213 | Pulmonx Corporation | Canadian Imperial Bank of Commerce | Security Interest |
| Sep 30, 2020 Reel 53952, frame 44 | Oxford Finance LLC, as Collateral Agent | Pulmonx Corporation | Release of Security Interest |
| Sep 30, 2020 Reel 53953, frame 548 | Boston Scientific Corporation | Pulmonx Corporation | Release of Security Interest |
| Jan 27, 2026 Reel 74570, frame 1 | Pulmonx Corporation | Canadian Imperial Bank of Commerce | Security Interest |
| Mar 2, 2026 Reel 75012, frame 453 | Pulmonx Corporation | Perceptive Credit Holdings V, LP, as Administrative Agent | Security Interest |
| Mar 4, 2026 Reel 75028, frame 274 | Canadian Imperial Bank of Commerce | Pulmonx Corporation | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jul 2029
Term ends Jul 23, 2029. No further fees fall due before then
Note
The 666 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
15
later US patents cite this one
That is above the median of utility patents granted in 2013 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.